|
gptkbp:instance_of
|
gptkb:immunotherapy
|
|
gptkbp:administered_by
|
oral tablet
|
|
gptkbp:approves
|
gptkb:1997
gptkb:FDA
|
|
gptkbp:available_on
|
generic medication
|
|
gptkbp:brand
|
clopidogrel bisulfate
|
|
gptkbp:clinical_trial
|
CAPRIE trial
CHARISMA trial
CURE trial
PLATO trial
TRITON-TIMI 38 trial
|
|
gptkbp:condition
|
gptkb:peripheral_artery_disease
gptkb:Cardiology
ischemic stroke
transient ischemic attack
acute coronary syndrome
|
|
gptkbp:contraindication
|
severe liver disease
active bleeding
|
|
gptkbp:dosage_form
|
300 mg tablet
300 mg loading dose
75 mg tablet
75 mg once daily
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:financial_support
|
avoid alcohol
inform healthcare provider of all medications
monitor for signs of bleeding
do not stop taking without consulting a doctor
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Plavix
|
|
gptkbp:ingredients
|
gptkb:clopidogrel
|
|
gptkbp:interacts_with
|
gptkb:esomeprazole
gptkb:omeprazole
gptkb:warfarin
NSAIDs
|
|
gptkbp:lifespan
|
8 hours
|
|
gptkbp:manufacturer
|
gptkb:Sanofi
gptkb:Bristol-Myers_Squibb
|
|
gptkbp:marketed_as
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:Japan
gptkb:United_States
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:requires
|
prescription only
|
|
gptkbp:side_effect
|
nausea
bruising
diarrhea
rash
bleeding
|
|
gptkbp:used_for
|
preventing blood clots
reducing the risk of stroke
reducing the risk of heart attack
|
|
gptkbp:bfsParent
|
gptkb:Sanofi_Aventis
|
|
gptkbp:bfsLayer
|
5
|